| Term 
 | Definition 
 
        | Muscarinic receptors, nicotinic at high doses metabolized by AChesterase produces parasympathetic effects Used in paralytic ileus and OAG dangerous in asthmatics, hypothyroidism, GI obstruction |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Muscarinic agonist, nicotinic at high doses not metabolized by AChesterase produces parasympathetic effects used in OAG |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Selective Muscarinic agonist not metabolized by AChesterase produces parasympathetic effects Used in post-operative ileus and urinary retention |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Selective Nicotinic agonist Crosses the BBB Produces excitation, addiction, increased arousal (amygdala, thalamus) Stimulation of autonomic ganglia, increases GI tone Used to aid in smoking cessation, ulcerative colitis, and Tourette's Syndrome Side effects: nausea, vomiting Associated with Mesolimbic reward system |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Partial agonist at the Alpha4Beta1 nicotinic receptor Activates nicotinic receptors somewhat less than nicotine Blocks nicotines access to the receptor Used in smoking cessation Side effects: neuropsychiatric symptoms |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Blocks AChesterase Enhances the action of ACh at nicotinic receptors in high doses Increases muscular contraction Used as a myasthenia gravis diagnostic tool because it only lasts 5-15 minutes   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Blocks AChesterase to enhance ACh Causes constriction of ciliary muscle Used in miotic glaucoma 30 min - 2 hour duration Crosses the BBB |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Blocks AChesterase to enhance ACh Enhances action of ACh at nicotinic receptors at high doses Used for myasthenia gravis (with atropine) Used in gut/bladder atony or to reverse paralysis produced by skeletal muscle blockers 30 min - 2 hour duration |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Blocks AChesterase Modest improvements in memory and cognition Used in Alzheimer's 24 hour duration Crosses BBB Available in pill or patch |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Blocks AChesterase Modest improvements in memory and cognition Used in Alzheimer's 12 hour duration Also enhances ACh binding to nicotinic receptors Side effects: nausea, diarrhea, insomnia |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Irreversibly binds AChesterase Produces overstimulation of muscarinic receptors SLUD Side effects: bronchoconstriction, miosis, sweating, bradycardia, hypotension, pulmonary edema, respiratory paralysis, ataxia, confusion, convulsions, coma Atropine will block muscarinic activation Pralidoxime will reactive AChesterase |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Blocks release of ACh into the synapse by cleaving SNAP25 Blocks effects of ACh at muscarinic receptors Used for blepharospasm, cosmetic Can cause excessive muscle paralysis |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Blocks ACh activation of muscarinic receptors Produces: tachycardia, prolonged mydriasis, inhibited secretions, constipation, retention, CNS excitement No effect on blood vessesl Used as a pre-anesthetic, anti-spasmodic, and anti-diarrheal Crosses the BBB Can be dangerous in OAG |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Blocks ACh activation of muscarinic receptors Bronchodilator Used in COPD Does not cross the BBB |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Blocks every ganglionic nicotinic receptor in sympathetic and parasympathetic system. Thus is also blocks the adrenergic release of NE Causes vasodilation, hypotension, tachycardia, mydriasis, reduced GI tone, decreased secretions, xerostomia, and decreased genital stimulation Used in AAA and to rapidly control BP |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Non-depolarizing skeletal nicotinic receptor blocker Causes muscle paralysis Used to eliminate muscle movements during surgery Side effects: hypotension due to mast cell degranulation Cam also block neuronal nicotinic receptors at high doses 2 hour duration Does not cross BBB Reversed by neostigmine + atropine |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Non-depolarizing skeletal nicotinic receptor blocker Causes muscle paralysis Used in surgery Side effects: less hypotension than tubocurarine 1 - 1.5 hour duration Reversed by neostigmine + atropine   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Depolarizing skeletal muscle nicotinic receptor blocker Causes muscle paralysis Used in endotracheal tube insertion Lasts very short time Metabolized by AChesterase Cannot be reversed Alternative: Rocuronium |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Reactives ACh that has been blocked by irreversible anti-AChesterase Reduces over-activation of muscarinic receptors Sarin antidote |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Skin, mucosa Constriction of skeletal muscle BV Constriction of ab viscera BV Constriction of pulmonary BV Contraction of GI sphincters Contraction of bladder Male and female orgasm and ejaculation Uterine contraction in pregnant women Epi > NE > Iso > DA > Doba |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Pre-synaptic nerve terminals |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Increased HR, conduction, and contractility Renin release from the JGA Iso > Epi > NE > DA > Dobu |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Dilation of skeletal muscle BV Dilation of ab viscera BV Decreased GI tone, increased motility, and secretion Bladder relaxation Uterine relaxation Epi > NE > Iso > DA > Doba |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Low dose: Beta 1 and Beta 2 High dose: Alpha 1 Beta 1: increased automaticity, rate, conduction, CO Beta 2: decrease BP (low dose), bronchodilation, glycogen breakdown Alpha 1: increase BP (high dose), bronchodilation, decreased glycogen synthesis, and decreased insulin secretion Used in anaphylactic shock, hypersensitivity reaction, cardiac arrest |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Neurotransmitter in postganglionic sympathetic neurons Same effects on heart as epi Increased BP (Alpha 1) with no change in cardiac output Used in cases of shock and spinal anesthesia |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Non-endogenous selective Beta agonist Beta 1: Increase HR, etc Beta 2: Decrease BP (vasodilation), bronchodilation Used in emergent heart block, in preparation for a pacemaker, or to relax bronchi if Beta 2 selective agonist is not available Will not cross BBB |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Dopamine receptor, Beta 1, and Beta 2 High dose: Alpha 1 Beta 1: increases HR BP net decreases due to above receptors Used in cardiogenic shock Side effects: excessive sympathetic stimulation and excessive dopamine stimulation (CTZ) No CNS effects |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Low dose: Beta 1 High dose: Beta 2, Alpha 1 Beta 1: Increase in HR but not contractility Alpha 1: Increase in BP at high doses Used in heart failure, open heart surgery, or acute MI Side effects: Arrhythmias A sympathomimetic Does not cross BBB |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | An alpha agonist primarily selective for Alpha 1 Decongestion of mucous membranes and pupillary dilation Side effects: excessive stimulation can elevate BP Not metabolized by MAO or COMT |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | A weak Alpha and Beta agonist Decongestion of mucous membranes and increase in BP Used as a nasal decongestant, pressor, and for CNS stimulation Side effects: CNS efects Not metabolized by MAO or COMT |  | 
        |  | 
        
        | Term 
 
        | Terbutaline and Albuterol |  | Definition 
 
        | Relatively selective for Beta 2 Bronchodilation Used in asthma Side effects: high doses can activate Beta 1 and cause heart effects |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | A CNS stimulant that encourages the release of NE from the nerve terminal via facilitated exchange Used in narcolepsy and weight reduction Side effects: CNS stimulation, PV effects, risk of abuse Not metabolized by MAO or COMT |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | CNS stimulant that encourage release of NE from the nerve terminal via faciliated exchange Used in ADHD Side effects: excess CNS stimulation, PV effects, risk of abuse |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Inhibits PDE and adenosine to cause sympathomimetic effect without adrenergic receptor binding Works downstream from cAMP to allow intracellular build up of NE Causes sensitization of cortex, respiratory area, increased HR, contractility, dilation of BV, and cerebral vascular constriction Used in alterness and relief of headache   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Inhibits PDE and adenosine to cause sympathomimetic effect without adrenergic receptor binding Works downstream from cAMP to allow intracellular build up of NE Causes sensitization of cortex, respiratory area, increased HR, contractility, dilation of BV, and cerebral vascular constriction Used bronchial asthma with Beta 2 Has less effects on heart and lungs, more CNS   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Reversible selective Alpha 1 antagonist Decreases BP with reflex tachycardia Used in HTN and BPH Side effects: postural hypotension, inhibition of ejaculation, nasal stuffiness |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Irreversible selective Alpha 1 antagonist Binds covalently for 24 hours Used in pheochromocytoma (with propanolol) Side effects: postural hypotension, reflex tachycardia, inhibition of ejaculation |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Non-selective alpha antagonist Alpha 1: decrease BP Alpha 2: prevents feedback inhibition of NE Causes greater reflex tachycardia due to Beta 1 stimulation Used in pheochromocytoma with propanolol |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Non-selective Beta antagonist Beta 1: decrease HR, contractility, conduction, renin Beta 2: increase TPR, slow recovery from hypoglycemia, increased TG/VLDL, increased airway resistance Causes NET decrease in BP Used in HTN, cardiac arrhythmias, angina, glaucoma, MI, Pheo, heart failure, performance anxiety Side effects: decreased CO, heart block, bronchospasm, CNS effects |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Non-selective Beta antagonist Decrease in aqueous humor production Same uses as Propanolol |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Selective Beta 1 antagonist Decreases HR, CO, conduction, renin Also affects Beta 2 at high doses Used for same reasons as propanolol Same adverse effects as propanolol Has less respiratory effects than non-selectives |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Most selective Beta 1 antagonist Same effects and indications of propanolol Has an 8 minute half life Less respiratory effects than non-selectives |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Alpha 2 agonist Binds to Alpha 2 to produce feedback inhibition of NE Blocks sympathetic outflow Used in essential HTN, reduction of opioid withdrawal, OAG, and ADHD Side effects: dry mouth, sedation, HTN crisis   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Binds to Alpha 2 to produce feedback inhibition of NE Blocks sympathetic outflow Used in essential HTN Side effects: autoimmune response Is a prodrug that is safe to use to pregnancy |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Enters the pre-synaptic terminal via diffusion Blocks VMAT and depletes NE |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Enters the pre-synaptic terminal via the NET Uncouples the AP from Ca entry Concentrated in NE vesicles and depletes NE   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Substrate for NET Enters pre-synaptic nerve terminal Displaces NE via facilitated exchange so that NE is release |  | 
        |  | 
        
        | Term 
 
        | Cocaine, Imipramine, Atomoxetine |  | Definition 
 
        | Blocks the NET (Atomoxine is selective) to increase NE in the synapse |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Carbonic anhydrase inhibitor that works at the proximal tubule Prevents reabsorption of HCO3- Decreases H+ secretion Decreases production of aqueous humor Used in OAG, urinary alkalinization, metabolic alkalosis, acute mountain sickness, epilepsy Side effects: hyperchloremic acidosis, hypersensitivity with sulfas Urine: increased HCO3-, Na+, K+, decreased Cl- Blood: increased H+ |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Most commonly used diuretic that works at the distal convoluted tubule Inhibits the NaCl anti-port Produces a hyperosmolar urine Used in HTN, CHF, hypercalciuria, and nephrogenic DI Works as ADH substitute Side effects: hyperkalemia, hypercalcemia, hypochloremic acidosis, increased TG/VLDL Urine: increased Na+, Cl-, K+, decreased Ca++ Blood: hypokalemia |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Most efficaceous diuretic Inhibits the NKCC and disrupts the positive lumen potential, causes diminished Mg and Ca reabsorption Inhibits a concentrated or dilute urine Decreases renal vascular resistance Used in pulmonary edema, hyperkalemia, acute renal failure Contraindicated with quinidine, hypersensitivity with sulfas Urine: increased NaCl, K, H, Mg, Ca, HCO3- Blood: hypokalemic alkalosis, hypochloremia |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Aldosterone antagonist that only works in the presence of aldosterone Prevents insertion of Na+ channels in CD Used to retain K, aldosteronism Side effects: hyperglycemia, gynecomastia, menstrual irregularities Causes increased secretion of NaCl and hyperkalemia |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | K sparing diuretic that does not require aldosterone. Works at the CD to block Na channels Used in conjunction with furosemide or hydrochlorothiazide or prevent hypokalemia Induces P450 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | An osmotic diuretic that is freely filtered Works at water permeable segments (PT, DL, CD) Increases osmotic activity of solute, preventing water reabsorption and favoring secretion Increases RBF, and decreases corticomedullary gradient Used in AKI, acute glaucoma, dialysis Decreases osmolarity of urine   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Non-peptide ADH antagonist that works at the collecting tubule basolateral membrane Used in SIADH, hyponatremia, and CHF Side effect: hypernatremia Increased urine volume with decreased osmolarity |  | 
        |  | 
        
        | Term 
 
        | First Generation H1 Antagonists |  | Definition 
 
        | Chlorpheniramine Diphenhydramine Dimenhydrinate   Used in OTC medications, anti-motion sickness, and sleep aid |  | 
        |  | 
        
        | Term 
 
        | Second generation H1 Antagonists |  | Definition 
 
        | Loratadine Fexofenadine   Metabolized by CYP3A4 Longer lasting Less CNS effects Used for allergic rhinitis |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Cimetidine Rantidine Famotidine   Prevent histamine stimulated acid secretion Used in ulcers, GERD, Zollinger-Ellison syndrome Side effects: prolactin, impotence, gyncomastia Can suppress first pass effect of alcohol |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Prevents mast cell degranulation Used in allergic rhinitis Side effects: itching, sneezing, and headache |  | 
        |  |